{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:58:49Z","timestamp":1759838329700,"version":"3.37.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA034389","DA046109","GM130461"],"award-info":[{"award-number":["DA034389","DA046109","GM130461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00213-022-06072-1","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T03:02:16Z","timestamp":1644375736000},"page":"819-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task"],"prefix":"10.1007","volume":"239","author":[{"given":"Andrea E.","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Wendy","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Finkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Selleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aelyn","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick A.","family":"Bevins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"52","key":"6072_CR1","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","volume":"65","author":"S Babb","year":"2017","unstructured":"Babb S, Malarcher A, Schauer G, Asman K, Jamal A (2017) Quitting smoking among adults \u2013 United States, 2000-2015. MMWR Morb Mortal Wkly Rep 65(52):1457\u20131464. https:\/\/doi.org\/10.15585\/mmwr.mm6552a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"6072_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yfrne.2007.07.003","volume":"29","author":"JB Becker","year":"2008","unstructured":"Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendocrinol 29(1):36\u201347. https:\/\/doi.org\/10.1016\/j.yfrne.2007.07.003","journal-title":"Front Neuroendocrinol"},{"key":"6072_CR3","first-page":"12","volume":"99","author":"NL Benowitz","year":"1990","unstructured":"Benowitz NL (1990) Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. NIDA Res Monogr 99:12\u201329","journal-title":"NIDA Res Monogr"},{"issue":"24","key":"6072_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"NL Benowitz","year":"2010","unstructured":"Benowitz NL (2010) Nicotine addiction. N Engl J Med 362(24):2295\u20132303. https:\/\/doi.org\/10.1056\/NEJMra0809890","journal-title":"N Engl J Med"},{"issue":"1","key":"6072_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00213-003-1621-9","volume":"172","author":"J Besheer","year":"2004","unstructured":"Besheer J, Palmatier MI, Metschke DM, Bevins RA (2004) Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats. Psychopharmacology 172(1):108\u2013117","journal-title":"Psychopharmacology"},{"issue":"8","key":"6072_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/cn5001028","volume":"5","author":"RA Bevins","year":"2014","unstructured":"Bevins RA, Besheer J (2014) Interoception and learning: import to understanding and treating diseases and psychopathologies. ACS Chem Neurosci 5(8):624\u2013631. https:\/\/doi.org\/10.1021\/cn5001028","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"6072_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1534582304272005","volume":"3","author":"RA Bevins","year":"2004","unstructured":"Bevins RA, Palmatier MI (2004) Extending the role of associative learning processes in nicotine addiction. Behav Cogn Neurosci Rev 3(3):143\u2013158. https:\/\/doi.org\/10.1177\/1534582304272005","journal-title":"Behav Cogn Neurosci Rev"},{"issue":"1","key":"6072_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbr.2006.10.026","volume":"177","author":"RA Bevins","year":"2007","unstructured":"Bevins RA, Penrod RD, Reichel CM (2007) Nicotine does not produce state-dependent effects on learning in a Pavlovian appetitive goal tracking task with rats. Behav Brain Res 177(1):134\u2013141. https:\/\/doi.org\/10.1016\/j.bbr.2006.10.026","journal-title":"Behav Brain Res"},{"key":"6072_CR9","first-page":"67","volume-title":"Performance on learning to associate a stimulus with positive reinforcement","author":"R Boakes","year":"1977","unstructured":"Boakes R (1977) In: Davis H, Hurwitz HMB (eds) Performance on learning to associate a stimulus with positive reinforcement. Lawrence Erlbaum Associates, Hillsdale, pp 67\u2013101"},{"issue":"3","key":"6072_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1901\/jeab.2006.130-04","volume":"85","author":"MN Branch","year":"2006","unstructured":"Branch MN (2006) How research in behavioral pharmacology informs behavioral science. J Exp Anal Behav 85(3):407\u2013423. https:\/\/doi.org\/10.1901\/jeab.2006.130-04","journal-title":"J Exp Anal Behav"},{"issue":"1","key":"6072_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/syn.10242","volume":"50","author":"AW Bruijnzeel","year":"2003","unstructured":"Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse (New York, NY) 50(1):20\u201328. https:\/\/doi.org\/10.1002\/syn.10242","journal-title":"Synapse (New York, NY)"},{"key":"6072_CR12","unstructured":"Centers for Disease Control and Prevention (2019) Current cigarette smoking among adults in the United States. Retrieved from: https:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/adult_data\/cig_smoking\/index.htm"},{"key":"6072_CR13","unstructured":"Centers for Disease Control and Prevention (2020) Smoking cessation: fast facts. Retrieved from: https:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/cessation\/smokingcessationfastfcts\/index.html#:~:text=In%202018%2C%2061.7%25%20of%20adult,who%20eve%20 moked%20had%20quit"},{"issue":"Pt A","key":"6072_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.neuropharm.2016.10.014","volume":"113","author":"S Charntikov","year":"2017","unstructured":"Charntikov S, Falco AM, Fink K, Dwoskin LP, Bevins RA (2017) The effect of sazetidine-A and other nicotinic ligands on nicotine-controlled goal-tracking in female and male rats. Neuropharmacology 113(Pt A):354\u2013366. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.014","journal-title":"Neuropharmacology"},{"issue":"10","key":"6072_CR15","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/jm050069n","volume":"48","author":"JW Coe","year":"2005","unstructured":"Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW et al (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48(10):3474\u20133477. https:\/\/doi.org\/10.1021\/jm050069n","journal-title":"J Med Chem"},{"issue":"3","key":"6072_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s002130100802","volume":"157","author":"MS Cousins","year":"2001","unstructured":"Cousins MS, Stamat HM, de Wit H (2001) Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology 157(3):243\u2013253. https:\/\/doi.org\/10.1007\/s002130100802","journal-title":"Psychopharmacology"},{"key":"6072_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm6845a2","volume":"68","author":"MR Creamer","year":"2018","unstructured":"Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, Jamal A, Neff L (2018) Tobacco product use and cessation indicators among adults \u2014 United States. MMWR Morb Mortal Wkly Rep 68:1013\u20131019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6072_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1124\/mol.104.001313","volume":"66","author":"MI Damaj","year":"2004","unstructured":"Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR (2004) Enantioselective selective effects of metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Mol Pharmacol 66:675\u2013682","journal-title":"Mol Pharmacol"},{"issue":"4","key":"6072_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s002130000497","volume":"151","author":"EC Donny","year":"2000","unstructured":"Donny EC, Caggiula AR, Rowell PP, Gharib MA, Maldovan V, Booth S, Mielke MM, Hoffman A, McCallum S (2000) Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology 151(4):392\u2013405","journal-title":"Psychopharmacology"},{"issue":"3-4","key":"6072_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","volume":"12","author":"LP Dwoskin","year":"2006","unstructured":"Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006) Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS drug Rev 12(3-4):178\u2013207. https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00178.x","journal-title":"CNS drug Rev"},{"key":"6072_CR21","unstructured":"Food and Drug Administration (FDA) (2020) Want to quit smoking? FDA-Approved Products Can Help. Retrieved from: https:\/\/www.fda.gov\/consumers\/consumer-updates\/want-quit-smoking-fdaapproved-productscan-help"},{"key":"6072_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0023-9690(79)90035-3","volume":"10","author":"BJ Farwell","year":"1979","unstructured":"Farwell BJ, Ayres JJB (1979) Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking (\u201cgoal tracking\u201d) in rats. Learn Motiv 10:295\u2013312","journal-title":"Learn Motiv"},{"issue":"3","key":"6072_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.clinthera.2009.03.021","volume":"31","author":"GD Garrison","year":"2009","unstructured":"Garrison GD, Dugan SE (2009) Varenicline: a first-line treatment option for smoking Cessation. Clin Ther 31(3):463\u2013491. https:\/\/doi.org\/10.1016\/j.clinthera.2009.03.021","journal-title":"Clin Ther"},{"issue":"1","key":"6072_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","volume":"296","author":"D Gonzales","year":"2006","unstructured":"Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR, Varenicline Phase 3 Study Group (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296(1):47\u201355. https:\/\/doi.org\/10.1001\/jama.296.1.47","journal-title":"JAMA"},{"key":"6072_CR25","unstructured":"Healthy People (2020) Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Available from: https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/tobacco-use"},{"issue":"17","key":"6072_CR26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","volume":"337","author":"RD Hurt","year":"1997","unstructured":"Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337(17):1195\u20131202. https:\/\/doi.org\/10.1056\/NEJM199710233371703","journal-title":"N Engl J Med"},{"issue":"8","key":"6072_CR27","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00213-020-05542-8","volume":"237","author":"YW Huynh","year":"2020","unstructured":"Huynh YW, Raimondi A, Finkner A, Kuck JD, Selleck C, Bevins RA (2020) Menthol blunts the interoceptive discriminative stimulus effects of nicotine in female but not male rats. Psychopharmacology 237(8):2395\u20132404. https:\/\/doi.org\/10.1007\/s00213-020-05542-8","journal-title":"Psychopharmacology"},{"key":"6072_CR28","doi-asserted-by":"publisher","first-page":"1-26. 10.18637\/","DOI":"10.18637\/jss.v082.i13","volume":"*82*(13)","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB (2017) lmerTest package: tests in linear mixed effects models. J Stat Softw *82*(13):1-26. 10.18637\/jss.v082.i13. https:\/\/doi.org\/10.18637\/jss.v082.i13","journal-title":"J Stat Softw"},{"issue":"3","key":"6072_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.pbb.2008.08.024","volume":"91","author":"MG LeSage","year":"2009","unstructured":"LeSage MG, Shelley D, Ross JT, Carroll FI, Corrigall WA (2009) Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacol Biochem Behav 91(3):461\u2013467. https:\/\/doi.org\/10.1016\/j.pbb.2008.08.024","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"6072_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213002-1183-2","volume":"164","author":"WJ Lynch","year":"2002","unstructured":"Lynch WJ, Roth ME, Carroll ME (2002) Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164(2):121\u2013137. https:\/\/doi.org\/10.1007\/s00213002-1183-2","journal-title":"Psychopharmacology"},{"issue":"3-4","key":"6072_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00213-005-0135-z","volume":"184","author":"DH Malin","year":"2006","unstructured":"Malin DH, Lake JR, Smith TD, Khambati HN, Meyers-Paal RL, Montellano AL, Jennings RE, Erwin DS, Presley SE, Perales BA (2006) Bupropion attenuates nicotine abstinence syndrome in the rat. Psychopharmacology 184(3-4):494\u2013503. https:\/\/doi.org\/10.1007\/s00213-005-0135-z","journal-title":"Psychopharmacology"},{"issue":"3","key":"6072_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/mol.106.025130","volume":"70","author":"KB Mihalak","year":"2006","unstructured":"Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70(3):801\u2013805. https:\/\/doi.org\/10.1124\/mol.106.025130","journal-title":"Mol Pharmacol"},{"issue":"1-3","key":"6072_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejphar.2007.01.046","volume":"561","author":"JE Murray","year":"2007","unstructured":"Murray JE, Bevins RA (2007) Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. Eur J Pharmacol 561(1-3):91\u2013104. https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.046","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"6072_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1101\/lm.2177411","volume":"18","author":"JE Murray","year":"2011","unstructured":"Murray JE, Walker AW, Li C, Wells NR, Penrod RD, Bevins RA (2011) Nicotine trained as a negative feature passes the retardation-of-acquisition and summation tests of a conditioned inhibitor. Learn Mem (Cold Spring Harbor N.Y.) 18(7):452\u2013458. https:\/\/doi.org\/10.1101\/lm.2177411","journal-title":"Learn Mem (Cold Spring Harbor N.Y.)"},{"key":"6072_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.pbr.2015.07.012","volume":"224","author":"MA Nader","year":"2016","unstructured":"Nader MA (2016) Animal models for addiction medicine: from vulnerable phenotypes to addicted individuals. Prog Brain Res 224:3\u201324. https:\/\/doi.org\/10.1016\/bs.pbr.2015.07.012","journal-title":"Prog Brain Res"},{"key":"6072_CR36","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"1996","unstructured":"National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington"},{"key":"6072_CR37","first-page":"7","volume":"7","author":"GC Nomikos","year":"1992","unstructured":"Nomikos GC, Damsma G, Wenkstern D, Fibiger HC (1992) Effect of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropharmacology. 7:7\u201314","journal-title":"Neuropharmacology."},{"issue":"3","key":"6072_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/01.fbp.0000132915.11693.8e","volume":"15","author":"MI Palmatier","year":"2004","unstructured":"Palmatier MI, Peterson JL, Wilkinson JL, Bevins RA (2004) Nicotine serves as a feature positive modulator of Pavlovian appetitive conditioning in rats. Behav Pharmacol 15(3):183\u2013194","journal-title":"Behav Pharmacol"},{"issue":"2","key":"6072_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2045125316629071","volume":"6","author":"K Patel","year":"2016","unstructured":"Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK (2016) Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol 6(2):99\u2013144. https:\/\/doi.org\/10.1177\/2045125316629071","journal-title":"Ther Adv Psychopharmacol"},{"issue":"5","key":"6072_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00023210-200115050-00005","volume":"15","author":"KA Perkins","year":"2001","unstructured":"Perkins KA (2001) Smoking cessation in women. Special considerations. CNS Drugs 15(5):391\u2013411. https:\/\/doi.org\/10.2165\/00023210-200115050-00005","journal-title":"CNS Drugs"},{"issue":"10","key":"6072_CR41","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/ntr\/ntx205","volume":"20","author":"KA Perkins","year":"2018","unstructured":"Perkins KA, Karelitz JL, Kunkle N (2018) Sex differences in subjective responses to moderate versus very low nicotine content cigarettes. Nicotine Tob Res 20(10):1258\u20131264","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"6072_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/14622200802097506","volume":"10","author":"KA Perkins","year":"2008","unstructured":"Perkins KA, Scott J (2008) Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res 10(7):1245\u20131250. https:\/\/doi.org\/10.1080\/14622200802097506","journal-title":"Nicotine Tob Res"},{"issue":"6663","key":"6072_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/34413","volume":"391","author":"MR Picciotto","year":"1998","unstructured":"Picciotto MR, Zoli M, Rimondini R, L\u00e9na C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391(6663):173\u2013177. https:\/\/doi.org\/10.1038\/34413","journal-title":"Nature"},{"key":"6072_CR44","unstructured":"R Core Team (2019) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/"},{"issue":"6","key":"6072_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/14622200500381384","volume":"7","author":"AS Rauhut","year":"2005","unstructured":"Rauhut AS, Dwoskin LP, Bardo MT (2005) Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Nicotine Tob Res 7(6):901\u2013907. https:\/\/doi.org\/10.1080\/14622200500381384","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"6072_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.neuropharm.2010.03.005","volume":"58","author":"CM Reichel","year":"2010","unstructured":"Reichel CM, Murray JE, Barr JD, Bevins RA (2010) Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine. Neuropharmacology 58(8):1237\u20131245. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.03.005","journal-title":"Neuropharmacology"},{"issue":"2","key":"6072_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/09595230100100642","volume":"22","author":"R Richmond","year":"2003","unstructured":"Richmond R, Zwar N (2003) Review of bupropion for smoking cessation. Drug Alcohol Rev 22(2):203\u2013220. https:\/\/doi.org\/10.1080\/09595230100100642","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"6072_CR48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","volume":"52","author":"H Rollema","year":"2007","unstructured":"Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52(3):985\u2013994. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.10.016","journal-title":"Neuropharmacology"},{"key":"6072_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2017_3","volume-title":"The Behavioral Neuroscience of Drug Discrimination. Current Topics in Behavioral Neurosciences","author":"JA Rosecrans","year":"2017","unstructured":"Rosecrans JA, Young R (2017) Discriminative stimulus properties of S(\u2212)-nicotine: \u201ca drug for all seasons\u201d. In: Porter J, Prus A (eds) The Behavioral Neuroscience of Drug Discrimination. Current Topics in Behavioral Neurosciences, vol 39. Springer, Cham. https:\/\/doi.org\/10.1007\/7854_2017_3"},{"issue":"4","key":"6072_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00213-002-1277-x","volume":"165","author":"M Shoaib","year":"2003","unstructured":"Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependence related effects of nicotine in rats. Psychopharmacology 165(4):405\u2013412. https:\/\/doi.org\/10.1007\/s00213-002-1277-x","journal-title":"Psychopharmacology"},{"key":"6072_CR51","first-page":"321","volume":"295","author":"JE Slemmer","year":"2000","unstructured":"Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321\u2013327","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"6072_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/pcc.v06n0403","volume":"6","author":"SM Stahl","year":"2004","unstructured":"Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S (2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 6(4):159\u2013166. https:\/\/doi.org\/10.4088\/pcc.v06n0403","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"4","key":"6072_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s002130050205","volume":"129","author":"IP Stolerman","year":"1997","unstructured":"Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology 129(4):390\u2013397. https:\/\/doi.org\/10.1007\/s002130050205","journal-title":"Psychopharmacology"},{"issue":"1","key":"6072_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF02245088","volume":"117","author":"IP Stolerman","year":"1995","unstructured":"Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117(1):2\u201320. https:\/\/doi.org\/10.1007\/BF02245088","journal-title":"Psychopharmacology"},{"key":"6072_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0079-6123(08)62482-6","volume":"79","author":"IP Stolerman","year":"1989","unstructured":"Stolerman IP, Reavill C (1989) Primary cholinergic and indirect dopaminergic mediation of behavioural effects of nicotine. Prog Brain Res 79:227\u2013237. https:\/\/doi.org\/10.1016\/s0079-6123(08)62482-6","journal-title":"Prog Brain Res"},{"issue":"2","key":"6072_CR56","doi-asserted-by":"publisher","first-page":"319 328","DOI":"10.1016\/j.pbb.2009.09.012","volume":"94","author":"AM Struthers","year":"2009","unstructured":"Struthers AM, Wilkinson JL, Dwoskin LP, Crooks PA, Bevins RA (2009) Mecamylamine,dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine. Pharmacol Biochem Behav 94(2):319 328. https:\/\/doi.org\/10.1016\/j.pbb.2009.09.012","journal-title":"Pharmacol Biochem Behav"},{"key":"6072_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pbb.2019.04.001","volume":"181","author":"BM Thompson","year":"2019","unstructured":"Thompson BM, Barrett ST, Bevins RA (2019) Exploring the interoceptive stimulus effects of nicotine and varenicline. Pharmacol Biochem Behav 181:9\u201316. https:\/\/doi.org\/10.1016\/j.pbb.2019.04.001","journal-title":"Pharmacol Biochem Behav"},{"key":"6072_CR58","unstructured":"United States Department of Human and Health Services (USHHS) (2020) Smoking cessation: a report of the surgeon general \u2013 key findings. Retrieved from: https:\/\/www.hhs.gov\/surgeongeneral\/reports-and-publications\/tobacco\/2020-cessation-sgrfactsheet-key-findings\/index.html"},{"key":"6072_CR59","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.15585\/mmwr.mm6744a2externalicon","volume":"67","author":"TW Wang","year":"2018","unstructured":"Wang TW, Asman K, Gentzke AS, Cullen KA, Holder-Hayes E, Reyes-Guzman C, Jamal A, Neff L, King BA (2018) Tobacco product use among Adults-United States, 2017. Morb Mortal Wkly Rep 67:1225\u20131232. https:\/\/doi.org\/10.15585\/mmwr.mm6744a2externalicon","journal-title":"Morb Mortal Wkly Rep"},{"key":"6072_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1037\/1064-1297.10.2.129","volume":"10","author":"JL Wiley","year":"2002","unstructured":"Wiley JL, LaVecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10:129\u2013135","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"6072_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/copd.s1121","volume":"3","author":"S Wilkes","year":"2008","unstructured":"Wilkes S (2008) The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis 3(1):45\u201353. https:\/\/doi.org\/10.2147\/copd.s1121","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"6072_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.physbeh.2007.01.003","volume":"90","author":"JL Wilkinson","year":"2007","unstructured":"Wilkinson JL, Bevins RA (2007) Bupropion hydrochloride produces conditioned hyperactivity in rats. Physiol Behav 90(5):790\u2013796. https:\/\/doi.org\/10.1016\/j.physbeh.2007.01.003","journal-title":"Physiol Behav"},{"key":"6072_CR63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/0269881109102518","volume":"24","author":"JL Wilkinson","year":"2010","unstructured":"Wilkinson JL, Carroll IF, Bevins RA (2010) An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine. J Psychopharmacol 24:817\u2013828. https:\/\/doi.org\/10.1177\/0269881109102518","journal-title":"J Psychopharmacol"},{"issue":"3","key":"6072_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1874473710902030243","volume":"2","author":"TE Wooters","year":"2009","unstructured":"Wooters TE, Bevins RA, Bardo MT (2009) Neuropharmacology of the interoceptive stimulus properties of nicotine. Curr Drug Abuse Rev 2(3):243\u2013255. https:\/\/doi.org\/10.2174\/1874473710902030243","journal-title":"Curr Drug Abuse Rev"},{"key":"6072_CR65","unstructured":"World Health Organization (WHO) (2019) Tobacco: Key facts. Retrieved from: https:\/\/www.who.int\/news-room\/factsheets\/detail\/tobacco"},{"key":"6072_CR66","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-2999(02)01554-6","volume":"443","author":"R Young","year":"2002","unstructured":"Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113\u2013118","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"6072_CR67","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1124\/mol.106.027318","volume":"70","author":"Y Xiao","year":"2006","unstructured":"Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ (2006) Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them. Mol Pharmacol 70(4):1454\u20131460","journal-title":"Mol Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06072-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:15:53Z","timestamp":1646216153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["6072"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06072-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}